Berman Howard's Form 4/A amendment
AmendedCoya Therapeutics, Inc. (COYA) · filed Jan 17, 2023
- Accession no.
- 0001493152-23-001702
- Filed
- Jan 17, 2023
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jan 4, 2023
This filing lists no transactions. It carries over 2 transactions from the original filing that it did not restate.
This amendment restates part of 0001493152-23-000227 (filed Jan 4, 2023). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Berman HowardCIK 0001952986 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001493152-23-000227 (filed Jan 4, 2023).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +10,000 | – | – | 10,000 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +5,000 | – | – | 5,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.